Suppr超能文献

糖尿病患者与非糖尿病患者行 Roux-en-Y 胃旁路术后全因和特定原因死亡率风险。

All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes.

机构信息

Obesity Institute, Geisinger Clinic, Danville, PA

Department of Psychology, Philadelphia College of Osteopathic Medicine, Philadelphia, PA.

出版信息

Diabetes Care. 2017 Oct;40(10):1379-1385. doi: 10.2337/dc17-0519. Epub 2017 Jul 31.

Abstract

OBJECTIVE

This study assessed all-cause and specific-cause mortality after Roux-en-Y gastric bypass (RYGB) and in matched control subjects, stratified by diabetes status.

RESEARCH DESIGN AND METHODS

RYGB patients were matched by age, BMI, sex, and diabetes status at time of surgery to nonsurgical control subjects using data from the electronic health record. Kaplan-Meier curves and Cox regression were used to assess differences in all-cause and specific-cause mortality between RYGB patients and control subjects with and without diabetes.

RESULTS

Of the 3,242 eligible RYGB patients enrolled from January 2004 to December 2015, control subjects were identified for 2,428 ( = 625 with diabetes and = 1,803 without diabetes). Median postoperative follow-up was 5.8 years for patients with diabetes and 6.7 years for patients without diabetes. All-cause mortality was reduced in RYGB patients compared with control subjects only for those with diabetes at the time of surgery (adjusted hazard ratio 0.44; < 0.0001). Mortality was not significantly improved in RYGB patients without diabetes compared with control subjects without diabetes (adjusted hazard ratio 0.84; = 0.37). Deaths from cardiovascular diseases ( = 0.011), respiratory conditions ( = 0.017), and diabetes = 0.011) were more frequent in control subjects with diabetes than in RYGB patients with diabetes. RYGB patients without diabetes were less likely to die of cancer ( = 0.0038) and respiratory diseases ( = 0.046) than control subjects without diabetes but were at higher risk of death from external causes ( = 0.012), including intentional self-harm ( = 0.025), than control subjects without diabetes.

CONCLUSIONS

All-cause mortality benefits of RYGB are driven predominantly by patients with diabetes at the time of surgery. RYGB patients with diabetes were less likely to die of cardiovascular diseases, diabetes, and respiratory conditions than their counterparts without RYGB.

摘要

目的

本研究评估了 Roux-en-Y 胃旁路术(RYGB)后以及在糖尿病状态分层的情况下,与匹配的对照组相比,所有原因和特定原因的死亡率。

研究设计和方法

使用电子健康记录中的数据,根据手术时的年龄、BMI、性别和糖尿病状态,对 RYGB 患者进行了与非手术对照组的匹配。使用 Kaplan-Meier 曲线和 Cox 回归评估了糖尿病和非糖尿病患者中 RYGB 患者与对照组之间的全因和特定原因死亡率差异。

结果

在 2004 年 1 月至 2015 年 12 月期间,纳入了 3242 名符合条件的 RYGB 患者,为 2428 名患者(625 名患有糖尿病,1803 名没有糖尿病)找到了对照组。糖尿病患者的术后中位随访时间为 5.8 年,非糖尿病患者为 6.7 年。与对照组相比,仅在手术时患有糖尿病的 RYGB 患者的全因死亡率降低(调整后的危险比为 0.44;<0.0001)。与对照组相比,无糖尿病的 RYGB 患者的死亡率没有显著改善(调整后的危险比为 0.84;=0.37)。患有糖尿病的对照组患者的心血管疾病(=0.011)、呼吸系统疾病(=0.017)和糖尿病死亡(=0.011)的发生率高于患有糖尿病的 RYGB 患者。无糖尿病的 RYGB 患者死于癌症(=0.0038)和呼吸系统疾病(=0.046)的可能性低于无糖尿病的对照组患者,但因外部原因(=0.012),包括故意自残(=0.025)而死亡的风险高于无糖尿病的对照组患者。

结论

RYGB 的全因死亡率获益主要由手术时患有糖尿病的患者驱动。与没有 RYGB 的患者相比,患有糖尿病的 RYGB 患者死于心血管疾病、糖尿病和呼吸系统疾病的可能性较小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba5/5606311/20b5933ee6f4/dc170519f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验